Phase I Study of Prolonged-Infusion Gemcitabine Combined with Cyclophosphamide in Patients with Metastatic Carcinoma of the Breast: Tolerability of an Optimal Dose Schedule

Publisher： Karger

E-ISSN： 1423-0232|77|1|63-70

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.1, 2009-06, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 330-337

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 635-641

Karger

Access to resources Recommend Favorite

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of High-Dose Leucovorin and 48-Hour 5-Fluorouracil Infusion in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

Chemoradiotherapy in Patients with Pancreatic Carcinoma: Phase-I Study with a Fixed Radiation Dose and Escalating Doses of Weekly Gemcitabine

By  

Pancreatology, Vol. 6, Iss. 1-2, 2006-04 ,pp. : 109-116

Karger

Access to resources Recommend Favorite

A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 25-32

Karger

Access to resources Recommend Favorite